Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in Series A Financing, to Offer Multinational Global Clinical Development Strategy
SHANGHAI, March 18, 2022 /PRNewswire/ -- Harvest Integrated Research Organization ("HiRO" or the "Company") announced the completion of its Series A financing in the tens of millions of US dollars. This round of investment is led by OrbiMed, with the participation from existing shareholder, Fontus Capital. Proceeds from this funding round will be mainly used to accelerate the development...
Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud
First of its kind initiative in India bringing wearable technology for post-surgery care. NEW DELHI and LONDON and SINGAPORE, March 18, 2022 /PRNewswire/ -- Manipal Hospitals, the second-largest healthcare services provider in India, today announced a strategic partnership with ConnectedLife built with Google Cloud to use Fitbit's wearable technology with ConnectedLife's virtual platform to...
HitGen Announces Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
CHENGDU, China, March 17, 2022 /PRNewswire/ -- Shanghai Stock Exchange listed company (688222.SH) HitGen Inc. ("HitGen") today announced that it has entered into a research collaboration agreement with Howard Hughes Medical Institute ("HHMI") and Duke University. The Principal Investigators for HHMI and Duke University who will oversee the collaboration will be Dr....
China CDE Approved First Universal CAR-T IND !
NANJING, China, March 17, 2022 /PRNewswire/ -- On March 17, 2022, China National Drug Administration Drug Review Center (CDE) approved first Universal Chemeric Antigen Receptor T (UCAR-T) cell drug (Acceptance No. : CXSL2101509). CTA101 is independently developed by Nanjing Bioheng Biotech Co., Ltd ( hereinafter referred as 'Bioheng'), targeting CD19 and CD22, for the indication of adult recurrent or...
Triastek and Siemens announce strategic collaboration to accelerate digital transformation of the pharmaceutical industry
NANJING, China, March 17, 2022 /PRNewswire/ -- Triastek, Inc. and Siemens Ltd., China have signed a strategic collaboration agreement to provide digital technologies for the global pharmaceutical industry. Combining Triastek's industry-leading 3D printing and digital pharmaceutical technologies and Siemens' global leadership in automation and digitization is expected to lead to innovative...
BioVaxys Announces Bioproduction of BVX-1021 for its Pan-Sarbecovirus Program in Collaboration with The Ohio State University
VANCOUVER, BC, March 17, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that it has entered into an agreement with Millipore-Sigma ("Millipore") a global Contract Development and Manufacturing Research Organization ("CDMO"), to manufacture a supply of GLP-grade BVX-1021, the Company's newly developed vaccine...
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
SEOUL, South Korea, March 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today announced the appointment of Glen Hansen, Ph.D., D(ABMM), FCCM, as the Head of Scientific and Medical Affairs of its United States subsidiary, Seegene Technologies. In this role, Dr. Hansen will provide clinical input...
EVERSANA unveils global price and market access solution NAVLIN by EVERSANA
Next generation price and market access platform combining data, software and insights into single ecosystem CHICAGO, March 17, 2022 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today unveiled NAVLIN by EVERSANA™, a new, comprehensive ecosystem of price and access solutions to help established...
Digital Transformation Takes Center Stage at Frost & Sullivan’s MEASA Best Practices Awards
18 awards were presented to companies demonstrating excellence in leadership and innovation at the virtual awards ceremony MUMBAI, India, March 17, 2022 /PRNewswire/ -- At the 9th edition of Frost & Sullivan's Best Practices Awards for the Middle East, Africa, and South Asia (MEASA) region on March 16, 2022, 18 awards were presented to companies demonstrating excellence, innovation, and leadership via the virtual...
First eye drops registered on the Australian Register of Therapeutic Goods (ARTG) to slow the progression of short-sightedness now available for children aged from 4 to 14 years old[1]
SYDNEY, March 17, 2022 /PRNewswire/ -- Aspen announced the Therapeutic Goods Administration (TGA) listing of a new medication to slow the progression of short-sightedness (myopia) in children and young teenagers. EIKANCE® 0.01% eye drops (atropine sulfate monohydrate 0.01%) are available on prescription for children aged 4 to 14 years, as a treatment to slow the progression of myopia and...
